EURAZEO (EPA:RF) | Finanzwire

REGULATED PRESS RELEASE

published on 05/11/2026 at 17:35, 6 days 4 hours ago

Disclosure of transactions in own shares from May 4 to May 8, 2026
BRIEF

published on 05/07/2026 at 17:40, 10 days 4 hours ago

Eurazeo Reveals Share and Voting Rights Details as of April 30, 2026

Voting Rights Shares EURAZEO Compliance April 2026
REGULATED PRESS RELEASE

published on 05/07/2026 at 17:35, 10 days 4 hours ago

Disclosure of the number of shares and the total number of voting rights as of April 30, 2026
Disclosure of the number of shares and voting rights of Eurazeo as of April 30, 2026 according to French commercial regulations and AMF rules

Voting Rights Shares EURAZEO Financial Disclosure AMF Regulations
BRIEF

published on 05/06/2026 at 17:40, 11 days 4 hours ago

Eurazeo Shareholders’ Meeting Approves Key Resolutions

Sustainability EURAZEO Dividend Increase Shareholders' Meeting Board Appointments
REGULATED PRESS RELEASE

published on 05/06/2026 at 17:35, 11 days 4 hours ago

COMBINED SHAREHOLDERS’ MEETING OF MAY 6, 2026
Eurazeo's Combined Shareholders' Meeting on May 6, 2026 approved resolutions, dividend increase, strategic plan progress, sustainability leadership, and future outlook. Read more at www.eurazeo.com

Sustainability EURAZEO Strategic Plan Dividend Increase Shareholders' Meeting
REGULATED PRESS RELEASE

published on 05/04/2026 at 17:35, 13 days 4 hours ago

Disclosure of transactions in own shares from April 27 to April 30, 2026
REGULATED PRESS RELEASE

published on 04/27/2026 at 17:35, 20 days 4 hours ago

Disclosure of transactions in own shares from April 20 to April 24, 2026
BRIEF

published on 04/23/2026 at 14:35, 24 days 7 hours ago

EURAZEO'S KURMA PARTNERS SECURES €215 MILLION FOR BIOFUND IV

Biotechnology Investments Venture Capital Kurma Partners Biofund IV
REGULATED PRESS RELEASE

published on 04/23/2026 at 14:30, 24 days 7 hours ago

KURMA PARTNERS, AN EURAZEO GROUP COMPANY, CLOSES €215 MILLION BIOFUND IV
Kurma Partners, a Eurazeo group company, closes €215 million Biofund IV, supporting disruptive therapeutic solutions for severe diseases. Total AUM now at €1 billion

EURAZEO AUM Kurma Partners Biofund IV Therapeutic Solutions
REGULATED PRESS RELEASE

published on 04/20/2026 at 17:35, 27 days 4 hours ago

Disclosure of transactions in own shares from April 13 to April 17, 2026

Published on 05/17/2026 at 15:20, 7 hours 2 minutes ago

China XLX Announces 2026 Q1 Results
Published on 05/16/2026 at 01:15, 1 day 21 hours ago

Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 01:00, 1 day 21 hours ago

Arctic Fox Adopts Semi-Annual Reporting
Published on 05/16/2026 at 00:00, 1 day 22 hours ago

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 23 hours ago

Golden Minerals Reports First Quarter 2026 Financial Results

View all ACCESSWIRE

Published on 05/16/2026 at 16:08, 1 day 6 hours ago

The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 2 days 2 hours ago

CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:30, 2 days 3 hours ago

Designated Person Notifications
Published on 05/15/2026 at 18:10, 2 days 4 hours ago

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 2 days 4 hours ago

Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio

View all EQS

Published on 05/15/2026 at 15:08, 2 days 7 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/13/2026 at 18:00, 4 days 4 hours ago

DDV monthly statement at April 30 2026
Published on 05/13/2026 at 17:45, 4 days 4 hours ago

Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
Published on 05/13/2026 at 17:45, 4 days 4 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
Published on 05/13/2026 at 17:40, 4 days 4 hours ago

Report on share repurchases from 6 to 12 May 2026

View all LES ECHOS COMFI WIRE

News